MISSING leadership by WHO Director Dr Margaret Chan

Test and treat Hepatitis C now!

Director-General Chan, in 2010, the Executive Board of the World Health Assembly tasked you with mobilizing political will and adequate resources for an effective response to the global viral hepatitis pandemic.

New hepatitis C virus (HCV) drugs coming out of the pipeline have demonstrated cure rates of up to 100%; the hepatitis C virus could feasibly be eradicated from the planet. Without World Health Organization (WHO) at the helm, this prediction will remain unattainable.

Since 2010, more than a million people have died from HCV although it is treatable and curable. Three to four million people are newly infected each year, although HCV is preventable. Most new infections occur among people who inject drugs, yet less than 4% of them have sufficient access to clean injecting equipment. This shocking public health failure allows the epidemic to continue spreading.

Only a tiny fraction of the 185 million people who have HCV are aware of it. Most live in low and middle-income countries (LMICs) and have no access to diagnostics, care, or treatment. Pegylated interferon (PEG-IFN), backbone of the current standard of care for HCV, is priced cruelly out of reach. Where there is access to HCV treatment, people who inject drugs are often denied it: merely 2-4% of people who inject drugs access treatment.

People who inject drugs who want to be treated for HCV are often forced to stop their drug use or enter an opioid substitution therapy (OST) program. Neither of these stipulations are justifiable on clinical grounds, but are forms of discrimination that stem from the moral judgment of people who inject drugs. People who are currently injecting or in an OST program respond as well to HCV treatment as those who are not.

The World Health Organization must act to increase global access to HCV diagnostics and treatment, in particular for people who inject drugs, by:

  • Speaking out frequently on the need for rights-based harm reduction services including needle and syringe programs (NSP), OST and integrated hepatitis C treatment on a scale that will reverse the HCV epidemic among PWID as recommended by WHO/UNAIDS/UNODC.
  • Providing technical support to countries to create access to affordable, high quality, effective and safe biosimilar and alternative pegylated interferon products.
  • Creating clear guidance on HCV screening and testing that explicitly recommends screening for people living with HIV, in whom HCV progresses rapidly, and in people who inject drugs.

Many countries are prepared to address their HCV epidemics, and we, people living with HCV and our advocates, are ready to be actively involved in the development of national plans to prevent and control HCV. Countries are waiting for WHO guidance in key areas that will empower us all to move forward.

You must not fail your mandate. We implore you to demonstrate true leadership through the mobilization of political will and the necessary resources to combat the global HCV epidemic.

Sign on


Attached documents

Document

PDF – 355 kb

1828 supporters

  • -- Santhanalakshmi

    Paneer HIV Positive Women Network

    India

  • Aarao Henrique

    Grupo Otimismo

    Brazil

  • abdelaziz tadjeddine

    APCS

    Algeria

  • Abdelwadoud Moaz

    Theodor Bilharz Research Institute

    Egypt

  • acasgi acasgi

    acasgi

    Spain

  • acosta victor hugo

    panambi

    Paraguay

  • Act Up Paris

    Act Up-Paris

    France

  • adams miguel

    vocal-ny

    United States

  • Agafonov Roman

    Russia

  • Agin Laura

    United States

  • Aguilar Luz Maria

    Fundacion Mexicana para la Salud Hepatica, A.C.

    Mexico

  • Agustian Edo

    Indonesian drug user network

    Indonesia

  • AICHA LAMRANI

    Asociation

    Morocco

  • Akar Ann

    HIV Alliance

    United States

  • Akhalkatsi Ani

    Open Society Georgia Foundation

    Georgia

  • Akhmedova Parvina

    PO TRUST+

    Tajikistan

  • Akinaka, MRA Ken

    Hepatitis Support Network of Hawai'i

    United States

  • Akopian Ruben

    Armenia

  • Alano Almeida Jaime

    Autônomo

    Brazil

  • Alba Manuel

    Asociación Itxarobide

    Spain

  • ALBERT GIL

    France

  • Alboraie Mohamed

    Al-Azhar University

    Egypt

  • alcaide denise

    France

  • AlChammas Bassam

    Syrian society for HIV-AIDS and related diseases struggle

    Syria

  • Alcántara Isabel

    Mexico

  • Alegret Mas Vicente

    Spain

  • alessio guidotti

    Italy

  • Alexandre Decherf

    France

  • Alexandre Jalbert

    Médecins du Monde

    France

  • Ali Mohammad

    Liver Foundation of Bangladesh

    Bangladesh

  • Alice Djenadek

    Positive-Generation

    Cameroon

  • Alieva Aizhan

    Kyrgyzstan

  • Alimova Ainura

    Central bank

    Kyrgyzstan

  • ALIYA YUSSUPOVA

    Kazakhstan

  • Allende Anta Consuelo

    Spain

  • Allumier Darren-Jurmé

    United States

  • alonso casanovas noemi

    Spain

  • Altabas Reñe Ana

    Ambit Prevenció

    Spain

  • alvarez joaquin

    Spain

  • alvarez urrutia rosa

    Spain

  • Alves dos Anjos Danielle

    Autonoma

    Brazil

  • Alves Filho Antonio

    Grupo Otimismo

    Brazil

  • ALVES SERRA MARISOL

    GRUPO ESPERANZA Y VIDA/MOVIMIENTO LATINOAMERICANO Y DEL CARIBE DE MUJERES POSITIVAS-URUGUAY

    Uruguay

  • Americo de Melo Joao

    Grupo Otimismo

    Brazil

  • AMISSI DJUMA PATRICK

    EPIH/ SOS HEPATITES RD CONGO

    Congo-Kinshasa

  • Andrade Carlos

    hepato.com

    Brazil

  • ANDRE Jean

    Médecins du Monde

    France

  • Andreo Christian

    AIDES

    France

  • andriotti fernandes fernando

    hepato.com

    Brazil

  • Angulo Mariano Hernan

    Spain